Hims & Hers Health: Questions Remain About Compounding Viability Post Resolution of Semaglutide Shortage

Medline: In Rare Move, FDA Revokes Regulatory Approval for Several Medical Devices Sold by Company

The FDA has revoked the regulatory approvals for several medical devices sold by Medline (MDLN), according to recent updates on the agency’s recall database. 22 Medline devices and kits are being...

House Judiciary Panel Counsel Cella, Paul Hastings Partner Murray Emerge as Early Contenders to Become DOJ Antitrust Head

Adam Cella, a senior House GOP counsel, and Michael Murray, who served at DOJ during President Donald Trump’s first term, have emerged as early contenders to take over the department’s antitrust...

Private Equity Investment in Clinical Trial Sites Raises Potential Antitrust, CPOM Concerns

Private equity’s growing interest in clinical trial sites and services raises questions about how increased consolidation will impact the cost and sustainability of pharmaceutical research and...